Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells

M. A. Dao, K. Hashino, I. Kato, Jan Nolta

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

Recent reports have indicated that there is poor engraftment from hematopoietic stem cells (HSC) that have traversed cell cycle ex vivo. However, inducing cells to cycle in culture is critical to the fields of ex vivo stem cell expansion and retrovital-mediated gene therapy. Through the use of a xenograft model, the current data shows that human hematopoietic stem and progenitor cells can traverse M phase ex vivo, integrate retroviral vectors, engraft, and sustain long-term hematopoiesis only if they have had the opportunity to engage their integrin receptors to fibronectin during the culture period. If cultured in suspension under the same conditions, transduction is undetectable and the long-term multilineage regenerative capacity of the primitive cells is severely diminished.

Original languageEnglish (US)
Pages (from-to)4612-4621
Number of pages10
JournalBlood
Volume92
Issue number12
StatePublished - Dec 15 1998
Externally publishedYes

Fingerprint

Hematopoietic Stem Cells
Stem cells
Fibronectins
Adhesion
Gene therapy
Cell Cycle
Fibronectin Receptors
Heterografts
Integrins
Suspensions
Cells
Hematopoiesis
Genetic Therapy
Cell Division
Stem Cells

ASJC Scopus subject areas

  • Hematology

Cite this

Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. / Dao, M. A.; Hashino, K.; Kato, I.; Nolta, Jan.

In: Blood, Vol. 92, No. 12, 15.12.1998, p. 4612-4621.

Research output: Contribution to journalArticle

@article{7c824688a88f4ebc80b971a511d4a81c,
title = "Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells",
abstract = "Recent reports have indicated that there is poor engraftment from hematopoietic stem cells (HSC) that have traversed cell cycle ex vivo. However, inducing cells to cycle in culture is critical to the fields of ex vivo stem cell expansion and retrovital-mediated gene therapy. Through the use of a xenograft model, the current data shows that human hematopoietic stem and progenitor cells can traverse M phase ex vivo, integrate retroviral vectors, engraft, and sustain long-term hematopoiesis only if they have had the opportunity to engage their integrin receptors to fibronectin during the culture period. If cultured in suspension under the same conditions, transduction is undetectable and the long-term multilineage regenerative capacity of the primitive cells is severely diminished.",
author = "Dao, {M. A.} and K. Hashino and I. Kato and Jan Nolta",
year = "1998",
month = "12",
day = "15",
language = "English (US)",
volume = "92",
pages = "4612--4621",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells

AU - Dao, M. A.

AU - Hashino, K.

AU - Kato, I.

AU - Nolta, Jan

PY - 1998/12/15

Y1 - 1998/12/15

N2 - Recent reports have indicated that there is poor engraftment from hematopoietic stem cells (HSC) that have traversed cell cycle ex vivo. However, inducing cells to cycle in culture is critical to the fields of ex vivo stem cell expansion and retrovital-mediated gene therapy. Through the use of a xenograft model, the current data shows that human hematopoietic stem and progenitor cells can traverse M phase ex vivo, integrate retroviral vectors, engraft, and sustain long-term hematopoiesis only if they have had the opportunity to engage their integrin receptors to fibronectin during the culture period. If cultured in suspension under the same conditions, transduction is undetectable and the long-term multilineage regenerative capacity of the primitive cells is severely diminished.

AB - Recent reports have indicated that there is poor engraftment from hematopoietic stem cells (HSC) that have traversed cell cycle ex vivo. However, inducing cells to cycle in culture is critical to the fields of ex vivo stem cell expansion and retrovital-mediated gene therapy. Through the use of a xenograft model, the current data shows that human hematopoietic stem and progenitor cells can traverse M phase ex vivo, integrate retroviral vectors, engraft, and sustain long-term hematopoiesis only if they have had the opportunity to engage their integrin receptors to fibronectin during the culture period. If cultured in suspension under the same conditions, transduction is undetectable and the long-term multilineage regenerative capacity of the primitive cells is severely diminished.

UR - http://www.scopus.com/inward/record.url?scp=0032535694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032535694&partnerID=8YFLogxK

M3 - Article

C2 - 9845527

AN - SCOPUS:0032535694

VL - 92

SP - 4612

EP - 4621

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -